Invention Grant
- Patent Title: Anti-CEA antibodies
- Patent Title (中): 抗CEA抗体
-
Application No.: US13408171Application Date: 2012-02-29
-
Publication No.: US08642742B2Publication Date: 2014-02-04
- Inventor: Thomas U. Hofer , Ralf Hosse , Ekkehard Moessner , Pablo Umana
- Applicant: Thomas U. Hofer , Ralf Hosse , Ekkehard Moessner , Pablo Umana
- Applicant Address: CH Schileren
- Assignee: Roche Glycart AG
- Current Assignee: Roche Glycart AG
- Current Assignee Address: CH Schileren
- Agency: Roche Glycart AG
- Priority: EP11156665 20110302
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K39/395
Abstract:
The present invention provides antigen binding molecules (ABMs) which bind membrane-bound CEA, including ABMs with improved therapeutic properties, and methods of using the same.
Public/Granted literature
- US20120251529A1 ANTI-CEA ANTIBODIES Public/Granted day:2012-10-04
Information query
